Pharma Pulse 4/10/25: Treating Chronic Cough with Digital Therapeutics, ADHD Stimulants Have Minimal Effect on Cardiovascular System & more
The latest news for pharma industry insiders.
Treating Chronic Cough with Digital Therapeutics
Hyfe’s CEO Tamsin Chislett spoke with Pharmaceutical Executive about this new technology, along with how digital therapeutics have the ability to change the ways that patient symptoms are captured and measured by HCPs. She also discussed how new technologies like AI are expanding opportunities to implement digital therapeutics across the industry.
Study Finds ADHD Stimulants Have Minimal Effect on Cardiovascular System
Small changes in blood pressure and pulse were shown in patients of all ages, and the authors suggested that these are monitored carefully in patients being treated for ADHD.
Global Pharma Stocks Slide on Tariff Threat
Shares in large US and European drugmakers slide, underperforming amid a broad market slump, after President Donald Trump said the US was planning to announce “a major tariff on pharmaceuticals” soon. BMO Capital Markets Biotech and Pharma Analyst Evan Seigerman has more on the story. (Source: Bloomberg)
GSK plc has announced the recipients of its COiMMUNITY Initiative grant program, awarding nearly $2 million to 15 regional, state and national non-profits and community-based groups working to boost adult immunization through improved vaccine education, outreach and access.
Looking forward to hearing more on how innovation can drive efficiency and excellence in operations at LogiPharma!
Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs
